How has been the historical performance of Supriya Lifesci.?

Answer:The historical performance of Supriya Lifesci shows a consistent growth in net sales and profitability over the years, with significant increases noted up to March 2025.

Breakdown:
Supriya Lifesci's net sales have shown a steady upward trend, increasing from 311.64 Cr in March 2020 to 696.49 Cr in March 2025. The total operating income followed a similar pattern, reaching 696.49 Cr in March 2025, up from 311.64 Cr in March 2020. The company's operating profit (PBDIT) also improved, peaking at 270.62 Cr in March 2025, compared to 109.45 Cr in March 2020. Profit before tax rose to 248.48 Cr in March 2025 from 96.20 Cr in March 2020, while profit after tax increased to 187.96 Cr in March 2025 from 73.37 Cr in March 2020. The earnings per share (EPS) reflected this growth, rising to 23.35 in March 2025 from 10.02 in March 2020. On the balance sheet, total assets increased significantly from 336.15 Cr in March 2020 to 1,112.31 Cr in March 2025, with total liabilities also rising to 1,112.31 Cr in March 2025, up from 336.15 Cr in March 2020. The company maintained a strong cash position, with closing cash and cash equivalents at 79.00 Cr in March 2025, compared to 74.00 Cr in March 2024. Overall, Supriya Lifesci has demonstrated robust growth in sales, profits, and asset base over the years.